Chapter Summary
Malaria, like other infectious diseases, leads to the development of autoimmunity. Multiple studies have reported various features of autoimmunity during malaria, such as polyclonal activation and autoantibody production. Autoimmunity during malaria has been hypothesized to play a role in parasite control and clearance. Conversely, autoimmunity has also been implied in contributing to most of the pathologies observed during complicated malaria. Autoimmune diseases shared many clinical and pathology features associated with clinical malaria. Genetic evidence has even suggested evolutionary links between the development of autoimmune disease and protections against clinical malaria. Although the presence of autoimmunity during malaria and other infections has been extensively reported, mechanistic insights and efforts to understand its role have proven to be challenging. The recent advancements achieved in understanding other autoimmune disorders can aid in understanding the presence and role of autoimmunity during infection. In this chapter, we aim to discuss the role that autoimmunity may play in both malaria protection and pathology. We also discuss various genetic and mechanistic evidences supporting the link between malaria and autoimmune diseases. Lastly, we conclude summarizing the evidence of autoimmunity during infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pradeu T, Cooper EL (2012) The danger theory: 20 years later. Front Immunol 3:287. doi:10.3389/fimmu.2012.00287
Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Infections and autoimmunity—friends or foes? Trends Immunol 30(8):409–414. doi:10.1016/j.it.2009.05.005
Rosenberg YJ (1978) Autoimmune and polyclonal B cell responses during murine malaria. Nature 274(5667):170–172
Consigny PH, Cauquelin B, Agnamey P, Comby E, Brasseur P, Ballet JJ, Roussilhon C (2002) High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals. Clin Exp Immunol 127(1):158–164
Liew J, Amir A, Chen Y, Fong MY, Razali R, Lau YL (2015) Autoantibody profile of patients infected with knowlesi malaria. Clin Chim Acta 448:33–38. doi:10.1016/j.cca.2015.06.006
Zandman-Goddard G, Shoenfeld Y (2009) Parasitic infection and autoimmunity. Lupus 18(13):1144–1148. doi:10.1177/0961203309345735
Smith KG, Clatworthy MR (2010) FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 10(5):328–343. doi:10.1038/nri2762
Adebajo AO (1997) Low frequency of autoimmune disease in tropical Africa. Lancet 349(9048):361–362
Butcher G (2008) Autoimmunity and malaria. Trends Parasitol 24(7):291–292. doi:10.1016/j.pt.2008.03.010
Jarra W (1983) Protective immunity to malaria and anti-erythrocyte autoimmunity. Ciba Found Symp 94:137–158
Daniel-Ribeiro CT, Zanini G (2000) Autoimmunity and malaria: what are they doing together? Acta Trop 76(3):205–221
Gimenez F, Barraud de Lagerie S, Fernandez C, Pino P, Mazier D (2003) Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci 60(8):1623–1635. doi:10.1007/s00018-003-2347-x
Chatzantoni K, Mouzaki A (2006) Anti-TNF-alpha antibody therapies in autoimmune diseases. Curr Top Med Chem 6(16):1707–1714
Perkins DJ, Were T, Davenport GC, Kempaiah P, Hittner JB, Ong’echa JM (2011) Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sci 7(9):1427–1442
Gazzinelli RT, Kalantari P, Fitzgerald KA, Golenbock DT (2014) Innate sensing of malaria parasites. Nat Rev Immunol 14(11):744–757. doi:10.1038/nri3742
Niewold TB (2014) Type I interferon in human autoimmunity. Front Immunol 5:306. doi:10.3389/fimmu.2014.00306
Kurien BT, Scofield RH (2008) Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 7(7):567–573. doi:10.1016/j.autrev.2008.04.019
Pleass RJ, Moore SC, Stevenson L, Hviid L (2016) Immunoglobulin M: restrainer of inflammation and mediator of immune evasion by Plasmodium falciparum malaria. Trends Parasitol 32(2):108–119. doi:10.1016/j.pt.2015.09.007
Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot EM, Goodnow CC, Carroll MC (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9(5):721–731
Stoute JA, Odindo AO, Owuor BO, Mibei EK, Opollo MO, Waitumbi JN (2003) Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. J Infect Dis 187(3):522–525. doi:10.1086/367712
Egan ES, Jiang RH, Moechtar MA, Barteneva NS, Weekes MP, Nobre LV, Gygi SP, Paulo JA, Frantzreb C, Tani Y, Takahashi J, Watanabe S, Goldberg J, Paul AS, Brugnara C, Root DE, Wiegand RC, Doench JG, Duraisingh MT (2015) Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion. Science 348(6235):711–714. doi:10.1126/science.aaa3526
Carroll MC (1998) CD21/CD35 in B cell activation. Semin Immunol 10(4):279–286. doi:10.1006/smim.1998.0120
Korir JC, Magambo JK, Mwatha JK, Waitumbi JN (2012) B-cell activity in children with malaria. Malar J 11:66. doi:10.1186/1475-2875-11-66
Kremlitzka M, Polgar A, Fulop L, Kiss E, Poor G, Erdei A (2013) Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. Int Immunol 25(1):25–33. doi:10.1093/intimm/dxs090
Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416(6881):603–607. doi:10.1038/416603a
Rosenberg EB, Strickland GT, Yang SL, Whalen GE (1973) IgM antibodies to red cells and autoimmune anemia in patients with malaria. Am J Trop Med Hyg 22(2):146–152
Abu-Shakra M, Shoenfeld Y (1991) Parasitic infection and autoimmunity. Autoimmunity 9(4):337–344
Daniel-Ribeiro C, Druilhe P, Monjour L, Homberg JC, Gentilini M (1983) Specificity of auto-antibodies in malaria and the role of polyclonal activation. Trans R Soc Trop Med Hyg 77(2):185–188
Fernandez-Arias C, Rivera-Correa J, Gallego-Delgado J, Rudlaff R, Fernandez C, Roussel C, Gotz A, Gonzalez S, Mohanty A, Mohanty S, Wassmer S, Buffet P, Ndour PA, Rodriguez A (2016) Anti-self phosphatidylserine antibodies recognize uninfected erythrocytes promoting malarial anemia. Cell Host Microbe 19(2):194–203. doi:10.1016/j.chom.2016.01.009
Lefrancois G, Bouvet E, le Bras J, Vroklans M, Simonneau M, Vachon F (1982) Anti-erythrocyte autoimmunisation during chronic Falciparum malaria. Lancet 1(8266):280–281
Wozencraft AO, Lloyd CM, Staines NA, Griffiths VJ (1990) Role of DNA-binding antibodies in kidney pathology associated with murine malaria infections. Infect Immun 58(7):2156–2164
Fernandez-Arias C, Lopez JP, Hernandez-Perez JN, Bautista-Ojeda MD, Branch O, Rodriguez A (2013) Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization. J Immunol 190(7):3363–3372. doi:10.4049/jimmunol.1103812
Owuor BO, Odhiambo CO, Otieno WO, Adhiambo C, Makawiti DW, Stoute JA (2008) Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia. Mol Med 14(3–4):89–97. doi:10.2119/2007-00093.Owuor
de Oliveira RB, Wang JP, Ram S, Gazzinelli RT, Finberg RW, Golenbock DT (2014) Increased survival in B-cell-deficient mice during experimental cerebral malaria suggests a role for circulating immune complexes. MBio 5(2), e00949-00914. doi:10.1128/mBio.00949-14
Eisenhut M (2009) Causes of reduced immune complex clearance in cerebral malaria. Parasite Immunol 31(2):59. doi:10.1111/j.1365-3024.2008.01074.x, author reply 60
Hirako IC, Gallego-Marin C, Ataide MA, Andrade WA, Gravina H, Rocha BC, de Oliveira RB, Pereira DB, Vinetz J, Diamond B, Ram S, Golenbock DT, Gazzinelli RT (2015) DNA-containing immunocomplexes promote inflammasome assembly and release of pyrogenic cytokines by CD14+ CD16+ CD64 high CD32 low inflammatory monocytes from malaria patients. MBio 6(6):e01605–e01615. doi:10.1128/mBio.01605-15
Wu X, Gowda NM, Kumar S, Gowda DC (2010) Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol 184(8):4338–4348. doi:10.4049/jimmunol.0903824
Lacerda MV, Mourao MP, Coelho HC, Santos JB (2011) Thrombocytopenia in malaria: who cares? Mem Inst Oswaldo Cruz 106(Suppl 1):52–63
Facer CA, Agiostratidou G (1994) High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria. Clin Exp Immunol 95(2):304–309
Owens S, Chamley LW, Ordi J, Brabin BJ, Johnson PM (2005) The association of anti-phospholipid antibodies with parity in placental malaria. Clin Exp Immunol 142(3):512–518. doi:10.1111/j.1365-2249.2005.02936.x
Berlin T, Zandman-Goddard G, Blank M, Matthias T, Pfeiffer S, Weis I, Toubi E, Singh S, Asherson R, Fraser A, Gilburd B, Sapir T, Levy Y, Lukac J, Rozman B, Kveder T, Shoenfeld Y (2007) Autoantibodies in nonautoimmune individuals during infections. Ann N Y Acad Sci 1108:584–593
Sene D, Piette JC, Cacoub P (2008) Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev 7(4):272–277. doi:10.1016/j.autrev.2007.10.001
Casares S, Richie TL (2009) Immune evasion by malaria parasites: a challenge for vaccine development. Curr Opin Immunol 21(3):321–330. doi:10.1016/j.coi.2009.05.015
Poels LG, van Niekerk CC, van der Sterren-Reti V, Jerusalem C (1980) Plasmodium berghei: T cell-dependent autoimmunity. Exp Parasitol 49(1):97–105
Lehmann PV, Targoni OS, Forsthuber TG (1998) Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol Rev 164:53–61
Butcher GA (1991) Does malaria select for predisposition to autoimmune disease? J R Soc Med 84(8):451–453
Safeukui I, Gomez ND, Adelani AA, Burte F, Afolabi NK, Akondy R, Velazquez P, Holder A, Tewari R, Buffet P, Brown BJ, Shokunbi WA, Olaleye D, Sodeinde O, Kazura J, Ahmed R, Mohandas N, Fernandez-Reyes D, Haldar K (2015) Malaria induces anemia through CD8+ T cell-dependent parasite clearance and erythrocyte removal in the spleen. MBio 6(1), e02493-14. doi:10.1128/mBio.02493-14
Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162(1):1–11. doi:10.1111/j.1365-2249.2010.04143.x
Howland SW, Claser C, Poh CM, Gun SY, Renia L (2015) Pathogenic CD8+ T cells in experimental cerebral malaria. Semin Immunopathol 37(3):221–231. doi:10.1007/s00281-015-0476-6
Sotgiu S, Angius A, Embry A, Rosati G, Musumeci S (2008) Hygiene hypothesis: innate immunity, malaria and multiple sclerosis. Med Hypotheses 70(4):819–825. doi:10.1016/j.mehy.2006.10.069
Elkon KB, Silverman GJ (2012) Naturally occurring autoantibodies to apoptotic cells. Adv Exp Med Biol 750:14–26. doi:10.1007/978-1-4614-3461-0_2
Nagata S, Hanayama R, Kawane K (2010) Autoimmunity and the clearance of dead cells. Cell 140(5):619–630. doi:10.1016/j.cell.2010.02.014
Bordmann G, Rudin W, Favre N (1998) Immunization of mice with phosphatidylcholine drastically reduces the parasitaemia of subsequent Plasmodium chabaudi chabaudi blood-stage infections. Immunology 94(1):35–40
Bate CA, Kwiatkowski D (1994) A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum. Infect Immun 62(12):5261–5266
Soares MP, Yilmaz B (2016) Microbiota control of malaria transmission. Trends Parasitol 32(2):120–130. doi:10.1016/j.pt.2015.11.004
Galili U (2013) Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits. Immunology 140(1):1–11. doi:10.1111/imm.12110
Stevenson MM, Riley EM (2004) Innate immunity to malaria. Nat Rev Immunol 4(3):169–180. doi:10.1038/nri1311
Mannoor K, Li C, Inafuku M, Taniguchi T, Abo T, Sato Y, Watanabe H (2013) Induction of ssDNA-binding autoantibody secreting B cell immunity during murine malaria infection is a critical part of the protective immune responses. Immunobiology 218(1):10–20. doi:10.1016/j.imbio.2012.01.018
Green TJ, Packer BJ (1984) A role for rheumatoid factor enhancement of Plasmodium falciparum schizont inhibition in vitro. Infect Immun 46(3):668–672
Zenonos ZA, Dummler SK, Muller-Sienerth N, Chen J, Preiser PR, Rayner JC, Wright GJ (2015) Basigin is a druggable target for host-oriented antimalarial interventions. J Exp Med 212(8):1145–1151. doi:10.1084/jem.20150032
Langhorne J, Duffy PE (2016) Expanding the antimalarial toolkit: targeting host-parasite interactions. J Exp Med 213(2):143–153. doi:10.1084/jem.20151677
Grant AV, Roussilhon C, Paul R, Sakuntabhai A (2015) The genetic control of immunity to Plasmodium infection. BMC Immunol 16:14. doi:10.1186/s12865-015-0078-z
Brownlie RJ, Lawlor KE, Niederer HA, Cutler AJ, Xiang Z, Clatworthy MR, Floto RA, Greaves DR, Lyons PA, Smith KG (2008) Distinct cell-specific control of autoimmunity and infection by FcγRIIb. J Exp Med 205(4):883–895. doi:10.1084/jem.20072565
Butcher GA (1996) Malaria and macrophage function in Africans: a possible link with autoimmune disease? Med Hypotheses 47(2):97–100
Willcocks LC, Carr EJ, Niederer HA, Rayner TF, Williams TN, Yang W, Scott JA, Urban BC, Peshu N, Vyse TJ, Lau YL, Lyons PA, Smith KG (2010) A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc Natl Acad Sci U S A 107(17):7881–7885. doi:10.1073/pnas.0915133107
Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N, Watkins NA, Floto RA, Smith KG (2007) Systemic lupus erythematosus-associated defects in the inhibitory receptor FcγRIIb reduce susceptibility to malaria. Proc Natl Acad Sci U S A 104(17):7169–7174. doi:10.1073/pnas.0608889104
Odorizzi PM, Wherry EJ (2012) Inhibitory receptors on lymphocytes: insights from infections. J Immunol 188(7):2957–2965. doi:10.4049/jimmunol.1100038
Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B, Kayentao K, Ongoiba A, Doumbo OK, Pierce SK (2009) Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183(3):2176–2182. doi:10.4049/jimmunol.0901297
Portugal S, Tipton CM, Sohn H, Kone Y, Wang J, Li S, Skinner J, Virtaneva K, Sturdevant DE, Porcella SF, Doumbo OK, Doumbo S, Kayentao K, Ongoiba A, Traore B, Sanz I, Pierce SK, Crompton PD (2015) Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function. Elife 4, e07218. doi:10.7554/eLife.07218
Muellenbeck MF, Ueberheide B, Amulic B, Epp A, Fenyo D, Busse CE, Esen M, Theisen M, Mordmuller B, Wardemann H (2013) Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J Exp Med 210(2):389–399. doi:10.1084/jem.20121970
Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, Tygrett LT, Waldschmidt TJ, Crompton PD, Harty JT (2012) Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 13(2):188–195. doi:10.1038/ni.2180
Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8(3):239–245. doi:10.1038/ni1443
Bonilla-Abadia F, Tobon GJ, Canas CA (2012) Possible influence of resistance to malaria in clinical presentation of rheumatoid arthritis: biological significance of natural selection. Arthritis 2012:670579. doi:10.1155/2012/670579
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rivera-Correa, J., Rodriguez, A. (2017). A Role for Autoimmunity in the Immune Response Against Malaria. In: Mota, M., Rodriguez, A. (eds) Malaria. Springer, Cham. https://doi.org/10.1007/978-3-319-45210-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-45210-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45208-1
Online ISBN: 978-3-319-45210-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)